180 Life Sciences Corp. Files 10-K Amendment
Ticker: FRMM · Form: 10-K/A · Filed: May 8, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 10-K/A |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
180 Life Sciences filed an amendment to their 2024 10-K. Check for updates.
AI Summary
180 Life Sciences Corp. filed an amendment (No. 2) to its Form 10-K for the fiscal year ended December 31, 2024. The company, previously known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. This filing was made on May 8, 2025, and pertains to their annual report.
Why It Matters
This amendment provides updated or corrected information for 180 Life Sciences Corp.'s annual report, which is crucial for investors to have the most accurate financial and operational data.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and does not introduce new material risks.
Key Numbers
- 001-38105 — SEC File Number (Identifies the company's filings with the SEC)
- 20241231 — Fiscal Year End (The end date of the reporting period)
- 20250508 — Filing Date (Date the amendment was submitted)
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- May 8, 2025 (date) — Filing date
- December 31, 2024 (date) — Fiscal year end
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is Amendment No. 2 to the Form 10-K for the fiscal year ended December 31, 2024. Specific details of the amendments are not provided in the header information but would be detailed within the document itself.
When was the original 10-K filed for the fiscal year ended December 31, 2024?
The header indicates the filing date for this amendment is May 8, 2025. The original 10-K would have been filed prior to this amendment.
What is the primary business of 180 Life Sciences Corp.?
180 Life Sciences Corp. is in the Pharmaceutical Preparations industry, with Standard Industrial Classification code 2834.
What was 180 Life Sciences Corp. previously named?
The company was formerly known as KBL Merger Corp. IV, with a date of name change on November 15, 2016.
Where is 180 Life Sciences Corp. headquartered?
The company's principal executive offices are located at 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on May 8, 2025 regarding 180 Life Sciences Corp. (FRMM).